Literature DB >> 19910703

PKC-alpha modulates TGF-beta signaling and impairs podocyte survival.

Irini Tossidou1, Gabriele Starker, Janna Kruger, Matthias Meier, Michael Leitges, Hermann Haller, Mario Schiffer.   

Abstract

BACKGROUND: Progressive loss of podocytes has been documented as an early lesion in the development of glomerular disease. In a variety of glomerular diseases, including diabetic nephropathy the activation of transforming growth factor-beta (TGF-beta) has been demonstrated to promote podocyte death and the development of glomerulosclerosis. In this manuscript we analyzed the role of PKC-alpha (PKCalpha) on TGF-beta1 induced apoptosis in podocytes.
METHODS: To accomplish this we generated stable murine PKCalpha deficient podocyte cell lines and examined survival- and pro-apoptotic signaling signatures as well as caspase activation after stimulation with TGF-beta.
RESULTS: After stimulation with TGF-beta we can demonstrate an enhanced and prolonged activation of PI3K/AKT and ERK1/2 in PKCalpha-knockout (PKCalpha-/-) podocytes compared to PKCalpha-wildtype (PKCalpha+/ +) podocytes, whereas proapoptotic signaling via p38MAPK is significantly reduced. Interestingly, activation of the Smad-pathway is also prolonged in the PKCalpha-/-podocytes. When we analyzed the underlying mechanisms we found a TGF-beta inducible interaction of PKCalpha with the TGF-beta-type-I-receptor (TGFbetaRI). Moreover, endocytosis assays showed that the TGFbetaRI is less internalized in PKCalpha-/- podocytes.
CONCLUSION: Since we can demonstrate a key role for PKCalpha in the signaling response after stimulation with TGF-beta we conclude that PKCalpha might be an interesting target molecule as a "podocyte protective" therapy. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910703     DOI: 10.1159/000257518

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

1.  Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.

Authors:  Ruma Pengal; Adam J Guess; Shipra Agrawal; Joshua Manley; Richard F Ransom; Robert J Mourey; Rainer Benndorf; William E Smoyer
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

Review 2.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

3.  Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease.

Authors:  A B White; F Galbiati; M I Givogri; A Lopez Rosas; X Qiu; R van Breemen; E R Bongarzone
Journal:  J Neurosci Res       Date:  2010-12-29       Impact factor: 4.164

4.  PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia.

Authors:  Ivo Quack; Magdalena Woznowski; Sebastian A Potthoff; Romy Palmer; Eva Königshausen; Sema Sivritas; Mario Schiffer; Johannes Stegbauer; Oliver Vonend; Lars Christian Rump; Lorenz Sellin
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

5.  Def-6, a novel regulator of small GTPases in podocytes, acts downstream of atypical protein kinase C (aPKC) λ/ι.

Authors:  Kirstin Worthmann; Michael Leitges; Beina Teng; Marcello Sestu; Irini Tossidou; Thomas Samson; Hermann Haller; Tobias B Huber; Mario Schiffer
Journal:  Am J Pathol       Date:  2013-10-03       Impact factor: 4.307

6.  Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis.

Authors:  Irini Tossidou; Beina Teng; Jan Menne; Nelli Shushakova; Joon-Keun Park; Jan U Becker; Friedrich Modde; Michael Leitges; Hermann Haller; Mario Schiffer
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

Review 7.  Therapeutic targets for treating fibrotic kidney diseases.

Authors:  So-Young Lee; Sung I Kim; Mary E Choi
Journal:  Transl Res       Date:  2014-08-13       Impact factor: 7.012

8.  Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.

Authors:  K S Hill; E Erdogan; A Khoor; M P Walsh; M Leitges; N R Murray; A P Fields
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

9.  All-trans retinoic acid up-regulates the human CD2AP gene expression through Sp1/Sp3 binding sites.

Authors:  Hua-Guo Xu; Rui Jin; Shan Gao; Wei Ren; Li Zou; Lifei Liu; Guo-Ping Zhou
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

10.  A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.

Authors:  Takahiro Ishikawa; Minoru Takemoto; Yoshihiro Akimoto; Aki Takada-Watanabe; Kunimasa Yan; Kenichi Sakamoto; Yoshiro Maezawa; Miyuki Suguro; Liqun He; Karl Tryggvason; Christer Betsholtz; Koutaro Yokote
Journal:  J Mol Med (Berl)       Date:  2021-02-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.